Top Suppliers:I want be here


1116571-01-7

1116571-01-7 structure
1116571-01-7 structure
  • Name: LIMK-IN-22j
  • Chemical Name: (2S)-N-(3-Bromophenyl)-N'-cyano-2-methyl-4-(5-methyl-7H-pyrrolo[2 ,3-d]pyrimidin-4-yl)-1-piperazinecarboximidamide
  • CAS Number: 1116571-01-7
  • Molecular Formula: C20H21BrN8
  • Molecular Weight: 453.34
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage LIM Kinase (LIMK)
  • Create Date: 2016-10-31 17:57:56
  • Modify Date: 2024-01-29 15:50:28
  • LIMK-IN-1 (Compound 14) is an inhibitor of LIM-Kinase (LIMK), with IC50s of 0.5 nM and 0.9 nM for LIMK1 and LIMK2, respectively. LIMK-IN-1 can be used for ocular hypertension and associated glaucoma research[1].

Name (2S)-N-(3-Bromophenyl)-N'-cyano-2-methyl-4-(5-methyl-7H-pyrrolo[2 ,3-d]pyrimidin-4-yl)-1-piperazinecarboximidamide
Synonyms LIMK-IN-22j
Description LIMK-IN-1 (Compound 14) is an inhibitor of LIM-Kinase (LIMK), with IC50s of 0.5 nM and 0.9 nM for LIMK1 and LIMK2, respectively. LIMK-IN-1 can be used for ocular hypertension and associated glaucoma research[1].
Related Catalog
Target

LIMK1:0.9 nM (IC50)

LIMK2:0.5 nM (IC50)

ROCK1:260 nM (IC50)

ROCK2:2700 nM (IC50)

References

[1]. Harrison BA, et.al. Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma. J Med Chem. 2009 Nov 12;52(21):6515-8.  

Molecular Formula C20H21BrN8
Molecular Weight 453.34
Exact Mass 452.10700
PSA 96.23000
LogP 3.56438
Hazard Codes Xn

~58%

1116571-01-7 structure

1116571-01-7

Literature: US2009/42893 A1, ; Page/Page column 9; 10 ; US 20090042893 A1
Precursor  2

DownStream  0